Dallas, TX-A new potential risk marker—monocyte chemoattractant protein-1 (MCP-1)—has been shown to provide independent prognostic value in ACS patients and might also be a good therapeutic target, ...
Atherogenesis is a chronic inflammatory process. Critical in the inflammation process is monocyte chemoattractant protein-1 (MCP-1). To locate genomic regions that affect circulating MCP-1 levels, a ...
TIMP-1 induces Fli-1 expression through miRNA-145, subsequently increasing MCP-1 expression and macrophage recruitment. MiRNA-145-enriched EVs from HSCs can transmit biological information and magnify ...
CRP-high sensitive was assayed on the Roche/Hitachi 911 analyzer using Tina-quant C-reactive protein high sensitive immunoturbidometric assay (Roche Diagnostics, Mannheim, Germany) using latex ...
Before desensitization was performed, oral and written informed consent was obtained from all patients or from their parent or guardian. Compilation of the data was recorded in accordance with ...
Researchers investigating the catabolic effect of parathyroid hormone (PTH) in hyperparathyroidism (HPT) have shown, for the first time, that monocyte chemoattractant protein-1 (MCP-1) is required for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results